TILE Institute Spring 2026 Speaker Series

March 17, 2026 Noon, Sullivan Hall Room 110

Regulating the Machine:

Law, Liability, Innovation, and the Future of AI-Driven Medicine

A conversation with Radiologist and Lunit Global Medical Director Dr. Christopher Austin

Healthcare in the US and globally is facing unprecedented headwinds, including rising costs, variable access, increasing consumer expectations, and growing concerns about clinician burnout. Artificial intelligence is frequently positioned as a potential solution to many of these operational and clinical challenges. Yet the adoption of AI remains limited, with industry innovation facing significant barriers of its own, particularly legal, regulatory, and policy challenges.

With roughly 75% of all FDA-cleared AI medical devices focused on diagnostic imaging, radiology has become the proving ground for many of the complex legal and regulatory questions surrounding the adoption and scaling of artificial intelligence in healthcare. These include issues related to liability, data governance, reimbursement, clinical accountability, and patient safety.

At the same time, rapid advances in computing power, foundation models, and data are accelerating innovation far faster than existing regulatory frameworks were designed to accommodate. The result is a growing tension between technological capability, patient protection, and legal oversight.

Join Seattle University of Law Professor Chryssa Deliganis for a conversation with Dr. Christopher Austin, MD, Radiologist and Global Medical Director at Lunit, who has been working at the forefront of artificial intelligence in diagnostic imaging since its emergence into clinical medicine in 2016. Together, they will explore how AI is reshaping the practice of medicine and how the evolving legal and regulatory environment is influencing which technologies reach patients, how they are deployed, and who bears responsibility when they fail.

About Dr. Christopher Austin

Dr. Christopher Austin is a UK-trained radiologist based in Seattle with nearly a decade of experience working at the intersection of artificial intelligence, diagnostic imaging, and clinical adoption. Since 2016, he has led development, validation, regulatory strategy, and commercialization efforts for AI-enabled imaging technologies. He has held senior leadership roles at GE Healthcare, Amazon Web Services (AWS), Kheiron Medical, and RadNet, and has advised multiple startups focused on the responsible deployment of clinical AI technologies.

In addition to his industry work, Dr. Austin has served as an advisor to the Scottish Government on AI in healthcare, contributing to national discussions on regulation, patient safety, and large-scale adoption of AI in clinical settings.

This event is part of the Technology, Innovation Law, and Ethics (TILE) Institute Spring 2026 Speaker Series, organized in collaboration with Seattle University's College of Nursing and Health Sciences.